The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review Long G. WangXiao M. LiuDaniel R. Budman REVIEW Pages: 355 - 361
Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bcl-2 Michael D. StoryRaymond E. Meyn ORIGINAL ARTICLE Pages: 362 - 366
Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs Michael D. StoryNena MirkovicRaymond E. Meyn ORIGINAL ARTICLE Pages: 367 - 371
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation David A. RinaldiJohn G. KuhnDaniel D. Von Hoff ORIGINAL ARTICLE Pages: 372 - 380
Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro Yasuhiko KanoMiyuki AkutsuSaburo Tsunoda ORIGINAL ARTICLE Pages: 381 - 388
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide Philip BealeIan JudsonMichael Brada ORIGINAL ARTICLE Pages: 389 - 394
Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance Jon C. MirsalisJanice Schindler-HorvatCharles A. Tyson ORIGINAL ARTICLE Pages: 395 - 402
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243) Cristiana SessaMassimo ZucchettiFranco Cavalli ORIGINAL ARTICLE Pages: 403 - 410
Antiangiogenic potential of camptothecin and topotecan Mark K. ClementsCarleton B. JonesSayed S. Daoud ORIGINAL ARTICLE Pages: 411 - 416
Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia Steven L. SoignetWilliam P. TongRaymond P. Warrell Jr. ORIGINAL ARTICLE Pages: 417 - 421
Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients Anders AndersenHarald HolteLars Slørdal ORIGINAL ARTICLE Pages: 422 - 426
Glutamyl hydrolase and the multitargeted antifolate LY231514 Myung S. RheeThomas J. RyanJohn Galivan ORIGINAL ARTICLE Pages: 427 - 432
Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors Bernd KasperStefan FruehaufW. Jens Zeller ORIGINAL ARTICLE Pages: 433 - 438
